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Clinical profile and outcomes of patients with
implanted IVC filter for deep vein thrombosis
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Background: Deep vein thrombosis (DVT) predisposes patients to
pulmonary vascular occlusion and its secondary effects. Antico-
agulant therapy has been widely used to prevent PTE. However,
anticoagulant therapy may be contraindicated for certain pa-
tients, particularly if interactions with concurrent medications or
any active bleeding is suspected; in such cases, the placement of
an inferior vena cava (IVC) filter may be appropriate. In the
absence of appropriate treatment, DVT may result in PE in
approximately 60% of cases and a highmortality rate of 30%e40 %.
Methods: Evaluate the clinical profile and outcomes of patient
with implanted IVC filter for Deep Venous Thrombosis. IVC filters
were placed as per standard guidelines.
Results: Total of 41subjects underwent IVC filter placement. The
assess site was femoral in 34 (82%) subjects and jugular in 7 (18%)
subjects. 1(2.5%) died of unrelated cause after one month of filter
insertion and 6(15%) people were lost for follow-up. No major or
fatal complications occurred intra-operatively and there were no
postprocedural complications. Among the 34 subjects the mean
follow up period was 6.5+/-3 months. Ten (25%) subjects are doing
fine without any complaints, 10 (25%) subjects complained of
persistent edema and leg pain, 1 (2.5%) had DVT in the contra-
lateral limb, 2(5%) had hyperpigmentation, 4(10%) people had
chronic thrombosis, 1 (2.5%) subjects had hematuria, bleed,
stroke, hematoma and varicose vein. And for 1 (2.5%) person,
successful retrieval of IVC filter was done.
Conclusion: IVC filter is a well-tolerated procedure, but needs
regular follow up as most patients have post thrombotic sequel
and requires management for the same.
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Background: Coronary artery disease appears as a pandemic with
increased incidence among the South Asian population particu-
larly the Indian subcontinent, occurring at an earlier age with
more extensive disease. It has been found that infarction and
cardiac failure are commonly associated with smaller coronary
arteries and attributed to the increased incidence and high mor-
tality in south Asian population than Caucasians. LMCA di-
mensions have important diagnostic and therapeutic
implications, since for any interventional procedure the absolute
size of the coronary artery matters.
Methods: 100 consecutive coronary angiograms were viewed
retrospectively. Patients with LM disease, ostioproximal LAD and
LCX disease, ectatic vessels were excluded. The LM was viewed in
the best two views, the length, diameter of LM at the level of
ostium and body were measured using QCA, during the diastolic
phase and average of two values taken.
Results: The average age of patients taken was 53.8 yrs. The
average BMI 24.2, and BSA 1.62.
The LM artery measured an average length of 8.9mm±2.6mm,
with a maximum of 19.41mm and minimum of 5.1 mm and 8
patients had separate origin of LAD and LCX. The average LM
diameter was 4.062 mm at origin and 4.24 at the body region. The
average LAD diameter was 3.04 mm and LCX was 3.10 mm. The
average ratio of LM diameter and sum of LAD, LCX and RAMUS
was 0.69. LM dimensions were similar in male and female pa-
tients. LM ostial diameter was significantly lower than the LM
body which may be the predisposing factor for ostial disease and
the LCX was almost the size of LAD irrespective of dominance.
Conclusion: Our study indicates LMCA dimension is similar to
that reported in west and contradict the general perception that
Indians have smaller coronary arteries. So the increased risk of
CAD and extensive disease may be attributed to other risk factors
than the size of coronaries.
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Background: Percutaneous balloonmitral valvuloplasty (BMV) can
be performed during pregnancy without significant maternal risk
or fetal morbidity or mortality. The present study was undertaken
to determine the pregancy outcomes, Apgar score of the neonates
born to mother after BMV in a large cohort of pregnant patients
with symptomatic mitral stenosis.
Methods: From January 2002 to June 2014, patient population
consisted of 80 consecutive pregnant women (mean gestational
duration, 22.72 weeks) with symptomatic rheumatic mitral ste-
nosis admitted to the hospital for BMV.
Results: All patients underwent clinical and obstetric evaluations,
electrocardiography, and 2-dimensional and Doppler echocardi-
ography. BMV was successful in all patients, resulting in a sig-
nificant increase in mitral valve area from 0.92 ± 0.2 to 2.06 ± 0.3
cm2. There were no embolic events or death related to the pro-
cedure. The mean gestational age at delivery time was 37.26 ± 2
weeks. Out of the 80 patients, 1 (1.25%) patient had missed abor-
tion and 1 (1.25%) undergo second trimester medical termination
of pregency (MTP). 43 (55.12%) patients had a normal delivery, 35
(44.87%) underwent cesarean section, 26 (33%) had a preterm de-
livery and there was 1 (1.28%) macerated stillbirth. Clinical data of
the infants were obtained from the assistant pediatricians.Out of
78 newborns, 75 (96.15%) newborns had normal weight (mean 2.94
kg) at delivery while 3 (3.84%) had low birth weight. The mean
Apgar scores at 1, 5 and 10 minutes after birth were 6.16, 7.16 and
8.37, respectively. 5 minutes Apgar scores below 7 were found in
50 newborns. 10 minutes Apgar score above 8 in all 78 newborns.
None of these newborns needed any special care andwere healthy
at discharge. At the time of follow-up children exhibited normal
growth and development and did not show any clinical abnor-
malities. No harmful effects due to the use of radiation were
observed in the children.
Conclusion: BMV is safe and effective, has a low morbidity and
mortality rate for the mother and the fetus, and has favorable
long-term results in fetus and pregnantwomenwith symptomatic
rheumatic mitral stenosis.
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